Goodwin’s Life Sciences team advised Moderna Therapeutics. Moderna Therapeutics and Merck (NYSE:MRK), known as MSD outside the United States and Canada, expanded their 2016 collaboration to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
